Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,355 | 54,864 | 44,395 | 70,933 | 29,910 |
| Receivables | 422 | 880 | 1,272 | 2,011 | 18,851 |
| Inventories | 2,594 | 3,607 | 3,591 | 4,182 | 4,542 |
| TOTAL | $53,339 | $63,863 | $53,467 | $80,505 | $55,938 |
| Non-Current Assets | |||||
| PPE Net | 3,950 | 4,148 | 4,391 | 4,646 | 4,841 |
| Other Non-Current Assets | 5,843 | 5,447 | 5,212 | 7,136 | 7,815 |
| TOTAL | $9,793 | $9,595 | $9,603 | $11,782 | $12,656 |
| Total Assets | $63,132 | $73,458 | $63,070 | $92,287 | $68,594 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,300 | 2,824 | 9,294 | 9,014 | 5,865 |
| Accounts payable and accrued liabilities | 13,381 | 11,180 | 10,279 | 6,356 | 6,297 |
| Accrued Expenses | 17,455 | 17,440 | 14,607 | 19,734 | 15,350 |
| Other current liabilities | 700 | 806 | 424 | 410 | 396 |
| TOTAL | $36,488 | $33,097 | $35,383 | $36,340 | $28,811 |
| Non-Current Liabilities | |||||
| Long Term Debt | 47,351 | 48,800 | 5,943 | 8,363 | 7,846 |
| Deferred Revenues | 652 | 847 | 779 | 826 | 903 |
| Other Non-Current Liabilities | 6,042 | 5,829 | 6,063 | 6,227 | 6,232 |
| TOTAL | $54,161 | $55,889 | $13,330 | $16,024 | $15,846 |
| Total Liabilities | $90,649 | $88,986 | $48,713 | $52,364 | $44,657 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,172 | 18,066 | 18,024 | 18,026 | 15,009 |
| Common Shares | 2,053,087 | 2,031,982 | 2,028,975 | 2,023,949 | 1,957,696 |
| Retained earnings | -2,069,480 | -2,036,888 | -2,004,291 | -1,975,695 | -1,931,501 |
| Other shareholders' equity | -11,124 | -10,622 | -10,327 | -8,331 | -2,258 |
| TOTAL | $-27,517 | $-15,528 | $14,357 | $39,923 | $23,937 |
| Total Liabilities And Equity | $63,132 | $73,458 | $63,070 | $92,287 | $68,594 |